130 related articles for article (PubMed ID: 25605852)
1. Precision immunology: the promise of immunotherapy for the treatment of cancer.
Kaufman HL
J Clin Oncol; 2015 Apr; 33(12):1315-7. PubMed ID: 25605852
[No Abstract] [Full Text] [Related]
2. Pancreatic cancer: vaccine is safe and improves survival.
Hutchinson L
Nat Rev Clin Oncol; 2015 Mar; 12(3):128. PubMed ID: 25645600
[No Abstract] [Full Text] [Related]
3. Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.
Le DT; Wang-Gillam A; Picozzi V; Greten TF; Crocenzi T; Springett G; Morse M; Zeh H; Cohen D; Fine RL; Onners B; Uram JN; Laheru DA; Lutz ER; Solt S; Murphy AL; Skoble J; Lemmens E; Grous J; Dubensky T; Brockstedt DG; Jaffee EM
J Clin Oncol; 2015 Apr; 33(12):1325-33. PubMed ID: 25584002
[TBL] [Abstract][Full Text] [Related]
4. Cracking the stone: combination vaccination and CTLA-4 blockade in pancreatic cancer.
Bajor DL; Vonderheide RH
J Immunother; 2013 Sep; 36(7):362-4. PubMed ID: 23924787
[No Abstract] [Full Text] [Related]
5. Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer.
Tsujikawa T; Crocenzi T; Durham JN; Sugar EA; Wu AA; Onners B; Nauroth JM; Anders RA; Fertig EJ; Laheru DA; Reiss K; Vonderheide RH; Ko AH; Tempero MA; Fisher GA; Considine M; Danilova L; Brockstedt DG; Coussens LM; Jaffee EM; Le DT
Clin Cancer Res; 2020 Jul; 26(14):3578-3588. PubMed ID: 32273276
[TBL] [Abstract][Full Text] [Related]
6. Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
Mizuguchi T; Torigoe T; Satomi F; Shima H; Kutomi G; Ota S; Ishii M; Hayashi H; Asakura S; Hirohashi Y; Meguro M; Kimura Y; Nishidate T; Okita K; Ishino M; Miyamoto A; Hatakenaka M; Sato N; Hirata K
Surg Today; 2016 Feb; 46(2):139-48. PubMed ID: 25649538
[TBL] [Abstract][Full Text] [Related]
7. Novel pancreatic cancer vaccines could unleash the army within.
Springett GM
Cancer Control; 2014 Jul; 21(3):242-6. PubMed ID: 24955709
[TBL] [Abstract][Full Text] [Related]
8. Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.
Blair AB; Zheng L
Chin Clin Oncol; 2017 Jun; 6(3):31. PubMed ID: 28705008
[TBL] [Abstract][Full Text] [Related]
9. [Advances in immunotherapy of pancreatic ductal adenocarcinoma].
Yang JQ; Wei T; Chen YW; Bai XL; Liang TB
Zhonghua Wai Ke Za Zhi; 2017 May; 55(5):396-400. PubMed ID: 28464583
[TBL] [Abstract][Full Text] [Related]
10. Vaccination for Pancreatic Ductal Adenocarcinoma: A Hard Nut to Crack.
Salas-Benito D; Melero I; Ponz-Sarvise M
Clin Cancer Res; 2019 Sep; 25(18):5435-5437. PubMed ID: 31315885
[TBL] [Abstract][Full Text] [Related]
11. T cell optimization for the treatment of pancreatic cancer.
Liu F; Saif MW
Expert Opin Biol Ther; 2017 Dec; 17(12):1493-1501. PubMed ID: 28835191
[TBL] [Abstract][Full Text] [Related]
12. Current advances in immunotherapy for pancreatic cancer.
Uram JN; Le DT
Curr Probl Cancer; 2013; 37(5):273-9. PubMed ID: 24331182
[No Abstract] [Full Text] [Related]
13. A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal epitopes.
Furukawa K; Tanemura M; Miyoshi E; Eguchi H; Nagano H; Matsunami K; Nagaoka S; Yamada D; Asaoka T; Noda T; Wada H; Kawamoto K; Goto K; Taniyama K; Mori M; Doki Y
PLoS One; 2017; 12(10):e0184901. PubMed ID: 29077749
[TBL] [Abstract][Full Text] [Related]
14. A Bacterial-Based Immunotherapy for PDAC.
Cancer Discov; 2022 Jun; 12(6):OF1. PubMed ID: 35394498
[TBL] [Abstract][Full Text] [Related]
15. The role of γδ T cells in pancreatic cancer: what could this mean for the clinic?
Daley D; Miller G
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):609-610. PubMed ID: 28345379
[No Abstract] [Full Text] [Related]
16. Q&A: Evidence presenter. Interview by Marian Turner.
Palucka K
Nature; 2013 Dec; 504(7480):S9. PubMed ID: 24352364
[No Abstract] [Full Text] [Related]
17. Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.
Loehrer AP; Kinnier CV; Ferrone CR
Adv Surg; 2016 Sep; 50(1):115-28. PubMed ID: 27520867
[No Abstract] [Full Text] [Related]
18. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.
Tanemura M; Miyoshi E; Nagano H; Eguchi H; Matsunami K; Taniyama K; Hatanaka N; Akamatsu H; Mori M; Doki Y
World J Gastroenterol; 2015 Oct; 21(40):11396-410. PubMed ID: 26523105
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant therapy for pancreatic cancer.
Kleeff J; Friess H; Büchler MW
Br J Surg; 2007 Mar; 94(3):261-2. PubMed ID: 17315287
[No Abstract] [Full Text] [Related]
20. Pancreatic ductal carcinoma: from the bench to the bedside.
Pezzilli R
JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251
[No Abstract] [Full Text] [Related]
[Next] [New Search]